Nasopharyngeal Carcinoma

Almeida, João Paulo; Brasil, Renato; Miyamura, Fernanda; Magarinos, Nicole; Portes, Alex; Neto, Alexandre Felippu

doi:10.7162/s1809-977720120s1po-124

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nasopharyngeal carcinoma (NPC) is a malignant tumor in the head and neck areas. Unlike other head and neck cancers, NPC is characterized by increased invasiveness and metastasis [ 1 , 2 , 3 , 4 ]. Clinical presentation of NPC is highly varied and often results in delayed or missed diagnosis due to its anatomical position [ 5 , 6 ].…”

Section: Introductionmentioning

confidence: 99%

Low-Dose Aspirin Use Significantly Improves the Survival of Late-Stage NPC: A Propensity Score-Matched Cohort Study in Taiwan

Luo

Chen

et al. 2020

Cancers

View full text Add to dashboard Cite

Background: Aspirin use has been associated with improved survival rates in various cancers. However, it remains unclear if aspirin confers a survival benefit on patients with nasopharyngeal carcinoma (NPC). The aim of this study was to assess the associations between aspirin use and survival in different stages of NPC. Methods: This is a 10-year retrospective cohort study of NPC patients. A total of 565 NPC patients were recruited after we performed a 1:4 propensity score match between aspirin users and non–users. Cox regression models with adjusted covariates were employed to evaluate factors that influence the survival rate of NPC patients. Results: The Kaplan-Meier analysis revealed that the overall survival (p < 0.0001) and disease-specific survival (p < 0.0001) rates of 180-day aspirin users increased. Increased survival rates were also observed in 180-day aspirin users with Stages III and IV, T, N1 and 2, and N3 categories. Cox regression models indicated that factors, including aspirin use (univariate: HR = 0.28, 95% CI = 0.14–0.55, p < 0.001; multivariate: HR = 0.23, 95% CI = 0.12–0.46, p < 0.001), were independent prognostic factors for survival. Conclusions: Aspirin use for more than 180 days is associated with an increased survival rate and is a positive independent prognostic factor in NPC.

show abstract

Section: Introductionmentioning

confidence: 99%